Application no. and date | 16798440.0 (espacenet) (Federated) (European Patent Register), 20161111 | Patent/reg. no. and date | DK/EP 3374509, 20201216 | Publication date | 20180919 | Priority no. and date | EP 15194367, 20151112, EP 16189502, 20160919 | EP pub. no. and date |
EP 3374509 20180919 | Effective date | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | Applicant ref. no. | P75687DK01 | Inventor | HOENER, Marius, F. Hoffmann-La Roche AG Grenzacherstrasse 124
4070 Basel, CH, COSTA, Veronica, F. Hoffmann-La Roche AG Grenzacherstrasse 124
4070 Basel, CH, HEDTJÄRN, Maj, Roche Innovation Center Copenhagen A/S Fremtidsvej 3, 2970 Hørsholm, DK, JAGASIA, Ravi, F. Hoffmann-La Roche AG Grenzacherstrasse 124
4070 Basel, CH, JENSEN, Mads Aaboe, Roche Innovation Center Copenhagen A/S Fremtidsvej 3, 2970 Hørsholm, DK, PATSCH, Christoph, F. Hoffmann-La Roche AG Grenzacherstrasse 124
4070 Basel, CH, PEDERSEN, Lykke, Roche Innovation Center Copenhagen A/S Fremtidsvej 3, 2970 Hørsholm, DK, RASMUSSEN, Søren Vestergaard, Roche Innovation Center Copenhagen A/S Fremtidsvej 3, 2970 Hørsholm, DK | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/712 (2006.01) , A61K 31/7125 (2006.01) , C12N 15/11 (2006.01) , C12N 15/113 (2010.01) | Title | Oligonukleotider til inducering af paternel UBE3A-ekspression | Int. application no. | EP2016077383 | Int. publication no. | WO2017081223 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|